This year’s BIOMED in Israel from the 14-16th June had for the 4th time a Danish delegation participating. This year was a mix of new contacts and old ones going back to Israel to find new contact or expand their work with existing contacts. All in all 15 companies were represented amongst these Novozymes, Novo Nordisk, Bioneer a VC company and in total 25 people occupied the stand. All companies had on the spot meetings and we must assume that more than 100 meetings took place.
As in the previous years it has been the Danish Embassy and DASTI that have been the organizers behind this successful event. This year our embassy was represented by our Economic Attaché Mr. Yaron Schrotter. He also assisted in setting up meetings for specific members of the delegation.
One of these was Prof. Mr. Peter Olesen from the Danish Strategic Research Council (this is a Council under DASTI), who was visiting Israel and Biomed for the first time. He was so impressed by what he saw and of the existing/future projects under Eureka/Eurostars that he wrote a memo to the Danish Minister of Science, Technology Mrs. Charlotte Sahl-Madsen (Conservative) about the possibility of expanding the bilateral work with Israel. He has also said the same in press:
http://www.dr.dk/P1/orientering/indslag/2010/06/23/164104.htm
“Vi lever i et innovationssamfund , og derfor er det vigtigt, at der lægges en nøje strategi for, hvor det kan betale sig for Danmark at sætte ind med forskning . Det siger formanden for Det Strategiske Forskningsråd , Peter Olesen. Han var for nylig på den årlige BioMed-konference i Tel Aviv i Israel, og han mener, at Danmark kan lære meget af Israel. I Israel bliver der nemlig gjort meget for at hjælpe forskerne med at få omsat deres ideer til produkter, der rent faktisk kan sælges. Peter Olesen foreslår, at Danmark udvider sin bilaterale aftale med Israel om forskningssamarbejde mellem virksomheder.”
Thursday, June 24, 2010
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.